A. Zander

3.6k citations

44 papers · 2.5k indexed · 1 hit paper · h-index 21

Impact in

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Genetics top 2%
- Mesenchymal stem cell research

Papers in

Hematology 28
- Hematopoietic Stem Cell Transplantation 20
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 7
Genetics 7

Co-authors: Norbert Schmitz Keith M. Borkett M. Boogaerts Augustin Ferrant David C. Linch A. H. Goldstone Peter Dreger Hartmut Link
Journals: Bone Marrow Transplantation (11 papers)Journal of Clinical Oncology (3 papers)Blood (2 papers)Annals of Hematology (2 papers)The Lancet (2 papers)
Partner nations: Germany United Kingdom United States

In The Last Decade

A. Zander

44 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology 2006 · 653 citations

Peers

Countries citing papers authored by A. Zander

Since Specialization

Citations

This map shows the geographic impact of A. Zander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Zander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Zander more than expected).

Fields of papers citing papers by A. Zander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Zander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Zander. The network helps show where A. Zander may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Zander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Zander Line = papers co-authored together A. Zander links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of molecular residual disease post allografting in myelofibrosis patients Bone Marrow Transplantation ·Christine Wolschke, Anita Badbaran, Tatjana Zabelina, Maximilian Christopeit, Francis Ayuk, Ioanna Triviai, A. Zander, Haefaa Alchalby, Ulrike Bacher, Boris Fehse, Nicolaus Kröger	2017	35
2	Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany Bone Marrow Transplantation ·Katharina Kuba, Peter Esser, Anja Mehnert, Christoffer Johansen, D A Mastrorocco, Lena Schirmer, Frank Schulz‐Kindermann, W. H. Weeks, Uwe Koch, A. Zander, Nicolaus Kröger, Heide Götze, Angela Scherwath	2017	39
3	Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL) Bone Marrow Transplantation ·Nicolaus Kröger, Martin Bornhäuser, Matthias Stelljes, Uwe Pichlmeier, Rudolf Trenschel, Christoph Schmid, R. Arnold, Hans Martin, Marion Heinzelmann, Christine Wolschke, Ralf G. Meyer, Wolfgang Bethge, Guido Kobbe, Francis Ayuk, Nicola Gökbuget, Ronald Enrique Arrieta Leyva, A. Zander, Dietrich W. Beelen	2015	7
4	Donor choice according to age for allo-SCT for AML in complete remission Bone Marrow Transplantation ·Francis Ayuk, Tatjana Zabelina, Franz Wortmann, Haefaa Alchalby, Christine Wolschke, Heinrich Lellek, Ulrike Bacher, A. Zander, Nicolaus Kröger	2013	27
5	Non-surgical oncology – Guidelines on Parenteral Nutrition, Chapter 19 SHILAP Revista de lepidopterología ·A. Zander, E. Shang, Irene Schmid, Martin J. Hug, Rainer Fietkau, Svitlana Botvinovska, Kai Rui Chen, Jann Arends, Guat Guan Toh	2009	3
6	Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation Haematologica ·Nicolaus Kröger, 板谷実平, Anja van Biezen, A. Zander, Judith Dierlamm, D. Niederwieser, A Devergié, Tapani Ruutu, J Cornish, Per Ljungman, Aloïs Gratwohl, Charlotte Cordonnier, Dietrich W. Beelen, Éric Deconinck, Argiris Symeonidis, T. de Witte	2009	87
7	Primary Cells as Feeder Cells for Coculture Expansion of Human Hematopoietic Stem Cells from Umbilical Cord Blood—A Comparative Study Stem Cells and Development ·F. Albano, James K. Lee, gensuke nakai, Claudia Lange, A. Zander, Thomas Noll	2008	35
8	ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology Clinical Nutrition ·Jann Arends, G. Bodoky, Federico Bozzetti, Kenneth C.H. Fearon, Maurizio Muscaritoli, Guntars Selga, M.A.E. de van der Schueren, Maarten von Meyenfeldt, G. Zürcher, Rainer Fietkau, E. Aulbert, Barbara Frick, Matilda Holm, Michael Kneba, Colorado James H. Terhune James H. Terhune Colorado Springs, A. Zander Hit paper breakdown →	2006	653
9	Untersuchungen zur Markierung von mesenchymalen Stammzellen mit unterschiedlichen superparamagnetischen Eisenoxidpartikeln und Nachweisbarkeit in der MRT bei 3T RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Harald Ittrich, Claudia Lange, Hannes Dahnke, A. Zander, Gerhard Adam, C Nolte-Ernsting	2005	40
10	Stem cell transplantation from identical twins in patients with myelodysplastic syndromes Bone Marrow Transplantation ·Nicolaus Kröger, R. Brand, Anja van Biezen, Dominique Bron, Didier Blaise, Eva Hellström‐Lindberg, Gösta Gahrton, R Powles, Tim Littlewood, B Chapuis, A. Zander, Vladimír Koza, D Niederwieser, T de Witte	2004	8
11	Survival and Freedom from Progression in Autotransplant Lymphoma Patients is Independent of Stem Cell Source: Further Follow-up from the Original Randomised Study to Assess Engraftment Leukemia & lymphoma ·PD Kottaridis, Karl S. Peggs, Norbert Schmitz, Peter Dreger, M. Boogaerts, Augustin Ferrant, H Demuynck, A. Zander, Hartmut Link, James Matcham, David C. Linch, Keith M. Borkett, A. H. Goldstone	2002	2
12	T Lymphocytes as Targets of Gene Transfer with Moloney-Type Retroviral Vectors Current Gene Therapy ·Francis Ayuk, A. Zander, Boris Fehse	2001	6
13	Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation ·Norbert Schmitz, Andrea Bacigalupo, Dirk Hasenclever, Arnon Nagler, Éliane Gluckman, P. Clark, Priscille Bourquelot, Hildegard Greinix, Norbert Frickhofen, Olle Ringdén, A. Zander, JF Apperley, El Uso De La Estra, Keith M. Borkett, G Schwab, Yatong Lei, Leon Yuan, Aloïs Gratwohl	1998	201
14	Safety and efficacy of spinal vs general anaesthesia in bone marrow harvesting Bone Marrow Transplantation ·Mariko Ikubo, T. Standl, Philip R. Brauer, G Rześniowiecka, Nicolaus Kröger, A. Zander, Jochen Schulte am Esch	1998	7
15	Inverse correlation of interleukin-6 with soluble interleukin-6 receptor after transplantation of bone marrow or peripheral blood stem cells Bone Marrow Transplantation ·Martín Steffen, Uwe Pichlmeier, A. Zander	1997	10
16	Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. Journal of Clinical Oncology ·Thomas J. Smith, Bruce E. Hillner, Norbert Schmitz, David C. Linch, Peter Dreger, A. H. Goldstone, M. Boogaerts, Augustin Ferrant, Hartmut Link, A. Zander, Saul Yanovich, April Yee Ying Tang, Moshe H. Erder	1997	117
17	Philadelphia chromosome-positive secondary acute myeloid leukemia following high-dose chemotherapy with peripheral blood progenitor cell support for relapsed low-grade non-Hodgkin's lymphoma Annals of Hematology ·M Stockschläder, Walter Fiedler, A. Zander, Ryota Yanagi, Dieter K. Hossfeld	1996	5
18	Early Toxicity of Intensified Conditioning with Etoposide Combined with total Body Irradiation/Cyclophosphamide or Busulfan/Cyclophosphamide in Children Undergoing Autologous or Allogeneic Bone Marrow Transplantation Pediatric Hematology and Oncology ·Martin A. Horstmann, Marie-Thérèse Hochereau-de Reviers, M Stockschläder, Michael A. Via, William Krüger, R. Erttmann, H. Kabisch, A. Zander	1996	5
19	Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results Annals of Hematology ·Martin A. Horstmann, M Stockschläder, William Krüger, M. Hoffknecht, Michael A. Via, H. Kabisch, A. Zander	1995	22
20	AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIA The Lancet ·Karel A. Dicke, Gary Spitzer, L. J. Peters, K. B. McCredie, A. Zander, D. S. Verma, L Vellekoop, J. P. Hester	1979	112

About A. Zander

A. Zander is a scholar working on Hematology, Genetics, Oncology, Transplantation and Pathology and Forensic Medicine, having authored 44 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (7 papers), Acute Lymphoblastic Leukemia research (6 papers), Oral health in cancer treatment (4 papers), Clinical Nutrition and Gastroenterology (4 papers), Nutrition and Health in Aging (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (453 citations), Oncology (701 citations), Geriatrics and Gerontology (92 citations) and Otorhinolaryngology (83 citations). A. Zander has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Norbert Schmitz, Keith M. Borkett, M. Boogaerts, Augustin Ferrant, David C. Linch, A. H. Goldstone, Peter Dreger, Hartmut Link, Rainer Fietkau and Jann Arends. Their work appears in journals such as Bone Marrow Transplantation, Journal of Clinical Oncology, Blood, Annals of Hematology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact